about
The beneficial effect of alpha-blockers for ureteral stent-related discomfort: systematic review and network meta-analysis for alfuzosin versus tamsulosin versus placeboIn search of the molecular mechanisms mediating the inhibitory effect of the GnRH antagonist degarelix on human prostate cell growthCombined low-frequency ultrasound and microbubble contrast agent for the treatment of benign prostatic hyperplasia.Effects of low-frequency ultrasound combined with microbubbles on benign prostate hyperplasia.Inhibition of chronic prostate inflammation by hyaluronic acid through an immortalized human prostate stromal cell line model.Roles of urology as assessed by an analysis of inpatients referred to urology.Metabolic syndrome is predictive of lower urinary tract symptom improvement after holmium laser enucleation of the prostate for benign prostatic obstruction.Obesity as a Risk Factor for Prostatic Enlargement: A Retrospective Cohort Study in Korea.Effect of transurethral resection of the prostate based on the degree of obstruction seen in urodynamic study.Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.Comparison of the efficacy and safety of tolterodine 2 mg and 4 mg combined with an α-blocker in men with lower urinary tract symptoms (LUTS) and overactive bladder: a randomized controlled trial.Potential of telmisartan in the treatment of benign prostatic hyperplasia.Therapy of calcium oxalate urolithiasis in a rhesus macaque (Macaca mulatta).The association of benign prostatic hyperplasia with lower urinary tract stones in adult men: A retrospective multicenter study.
P2860
Q26863732-197F2C20-AB8B-4561-A29F-4E2708815DB4Q28545022-075D2DF6-B976-4CCE-A486-8B0F2AE83A3EQ30433792-53BFA9FB-3DA3-4B91-851C-2E08947958F3Q30446785-3329163C-D907-4FE8-9B58-07A971121ABBQ33739217-F0C97156-D46E-462A-80E1-81A0D91ABBA6Q36284747-879B0855-544C-4E92-AE8B-27E78B3A071BQ36329234-CA77AF21-B268-4F85-B5CB-6336723292B4Q37553992-C1219AE0-8D0E-4EA1-8648-580B7FA250EEQ42033513-32900AB4-33BC-4E0E-A647-979CFF03B857Q47434739-189D1614-AD3E-4B9A-BA22-547B60BD1E8BQ47980799-2B7BB94D-A323-4F73-ABA3-E27C630E2E57Q48093199-52120B8D-64D2-4CFE-814F-0B1962626C77Q53742515-7CBE61B8-8C9E-42E5-BA6B-8606EA287733Q55331840-8E169C65-4720-41AB-98CE-D86B3EA1050C
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Benign prostatic hyperplasia: from bench to clinic
@ast
Benign prostatic hyperplasia: from bench to clinic
@en
Benign prostatic hyperplasia: from bench to clinic
@nl
type
label
Benign prostatic hyperplasia: from bench to clinic
@ast
Benign prostatic hyperplasia: from bench to clinic
@en
Benign prostatic hyperplasia: from bench to clinic
@nl
prefLabel
Benign prostatic hyperplasia: from bench to clinic
@ast
Benign prostatic hyperplasia: from bench to clinic
@en
Benign prostatic hyperplasia: from bench to clinic
@nl
P2860
P1476
Benign prostatic hyperplasia: from bench to clinic
@en
P2093
Hee Ju Cho
Tag Keun Yoo
P2860
P304
P356
10.4111/KJU.2012.53.3.139
P577
2012-03-19T00:00:00Z